Find Clinical Trials
Effect of ivabradine versus placebo on cardiac function, exercise capacity, and neuroendocrine activation in patients with Chronic Heart Failure with Preserved left ventricular Ejection Fraction An 8-month, randomised double-blind, placebo controlled, international, multicentre study. EDIFY
Servier Protocol Code:
CL2-16257-101
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2012-002742-20
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Heart failure
- IVABRADINE
- S016257
Other study id numbers
Other identification numbers the study may be known by.
- CL2-16257-101